Invention Grant
- Patent Title: Meningococcus vaccines
-
Application No.: US15319665Application Date: 2015-07-16
-
Publication No.: US11707513B2Publication Date: 2023-07-25
- Inventor: Alessia Biolchi , Brunella Brunelli , Marzia Monica Giuliani , Vega Masignani
- Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee Address: BE Rixensart
- Priority: EP 177563 2014.07.17
- International Application: PCT/EP2015/066229 2015.07.16
- International Announcement: WO2016/008961A 2016.01.21
- Date entered country: 2016-12-16
- Main IPC: A61K39/095
- IPC: A61K39/095 ; C07K14/22 ; A61K39/00 ; A61K39/385
Abstract:
Meningococcal vaccines can be improved by including multiple alleles or variants of fHbp, in order to provide broader coverage of the diversity which is known for this protein, and/or by reducing the quantity of an OMV component in each dose.
Public/Granted literature
- US20180214531A1 MENINGOCOCCUS VACCINES Public/Granted day:2018-08-02
Information query
